Something went wrong with the connection!

Nebulizer Market Driven By Rising Incidence Of Chronic Respiratory Diseases Till 2027: Grand View Research Inc.

 Breaking News
  • No posts were found

Nebulizer Market Driven By Rising Incidence Of Chronic Respiratory Diseases Till 2027: Grand View Research Inc.

May 29
16:02 2020
Nebulizer Market Driven By Rising Incidence Of Chronic Respiratory Diseases Till 2027: Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to nebulizer market growth.

The global nebulizer market size is expected to reach USD 1.5 billion by 2027, expanding at a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising incidence rate of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population worldwide are the major factors leading to market growth.

According to the Population Reference Bureau report, “Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. Therefore, growing geriatric population is expected to expand the patient pool for manufacturers and propel the growth of the market.

On the other hand, drug loss during nebulization is the major factor restraining the market. However, this can also act as an opportunity for the mesh nebulizer manufacturers as the devices are manufactured to deliver accurate drug dosage while reduce drug loss. Furthermore, increasing commercial acceptance of mesh nebulizers due to accurate delivery of drug to the lung and lower residual volumes also aids in market growth.

Technological advancements such as drug-device combination is further expected to create new opportunity in the market. The key manufacturers are expected to dominate the market of drug device combinations till the generic mesh nebulizer manufacturers invest in the support infrastructure required for the development of new pharmaceuticals. For instance, in 2016, Sunovion filed the first application for the approval of SUN-101. A mesh nebulizer in combination with a drug for COPD (SUN-101) will be a significant step for boosting the adoption of nebulizers. Other companies such as Vectura also have products in late stage development, e.g., VR475, indicated for severe asthma, in Phase III trials.

Get Details For “Sample Report, TOC, Segmentation & methodology of Nebulizer Market” Click Link Below:
https://www.grandviewresearch.com/industry-analysis/nebulizers-market

North America nebulizer market size, by type, 2016 - 2027 (USD Million)

Further key findings from the study suggest:

  • The jet segment held over 60.0% market share in 2019 owing to the greater penetration and low cost of the devices

  • The mesh segment is expected to be the fastest growing segment with a CAGR of 7.7% over the forecast period, due to various benefits including portability, convenience, homecare application, and accurate dosage delivery

  • According to the Population Reference Bureau report, “Aging in the United States”, the geriatric population in U.S. is estimated to increase from 48 million in 2016 to 98 million by 2060

  • The demand is expected to increase in homecare application. Easy availability of compact nebulizers that are ideal for home use and technological innovations in the device to reduce the sound created by it and to improve its functionality are increasing its adoption in home healthcare

  • North America dominated the nebulizer market in 2019. This high share can be attributed to increase in incidence of respiratory diseases, supportive government policies, favorable reimbursement schemes, rise in awareness, and increasing use of home care products

  • As per the analysis of the U.S. and EU clinical trial databases, mesh nebulizers are more preferred for clinical trials sponsored by pharmaceutical companies over jet nebulizers

  • Key players include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied Healthcare Products, Inc.; Becton Dickinson and Company; Agilent Technologies; Medline Industries; Briggs Healthcare; Drive Medical; and GF Health Products, Inc.

Would you Like to Take a Look On “Sample Report” of Nebulizer Market Click the Link Below:

https://www.grandviewresearch.com/industry-analysis/nebulizers-market/request/rs1

Global nebulizer market share, by end use, 2019 (%)

 

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/972/ibb

Grand View Research has segmented the global nebulizer market on the basis of the type, end use, and region:

Nebulizer Type Outlook (Revenue, USD Million, 2016 – 2027)

  • Jet

  • Mesh

    • Active

    • Passive

  • Ultrasonic

Nebulizer End-Use Outlook (Revenue, USD Million, 2016 – 2027)

  • Hospitals and clinics

  • Emergency Centers

  • Home Healthcare

Nebulizer Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Singapore

    • Malaysia

    • Indonesia

    • Philippines

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 126 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 4126 analysts and consultants, the company adds 121200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 600 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/nebulizers-market

Related Articles

Calendar

September 2020
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Categories